SECTION 527:1-1-2. Description of organization  


Latest version.
  • (a)   The Board is created by the Oklahoma Legislature, 59 O.S. 1996 Supp. §2053. The Board has the authority and duty to regulate and administer the practice of perfusion in this state.
    (b)   The Board consists of nine (9) members who are qualified and appointed in accordance with the provisions of 59 O.S. 1996 Supp. §2053 and §2054.
    (c)   Officers of the Board, Terms of office, and Vacancy. The officers of the Board shall be, in order of seniority, the Chair, Vice Chair, and Executive Secretary. Effective January 1, 2021, the officers of the Board shall serve one three-year term, with the exception of the Chair who shall only serve as Chair for one (1) year, and shall be elected at the first meeting after January 1 of the same year by a majority vote of the members attending the meeting. Each succeeding year, the Vice-Chair shall become the Chair, the Executive Secretary shall elevate to be the Vice-Chair, and a new Executive Secretary shall be elected by the Board. Should any officer be unable to serve due to death, incapacity, or resignation, the next most senior officer, except in the case of a vacancy in the office of Executive Secretary, shall assume the vacant office and fulfill the unexpired year. He or she shall subsequently succeed himself or herself in the same office for a full year as if he or she had been elevated as set forth above. In the case of a vacancy in the office of Executive Secretary, the Board shall elect a new Executive Secretary at its next meeting to serve the unexpired portion of the year and will be subject to a retention vote at the first meeting of the year after January 1.
    (d)   Absence of Chair and Vice Chair. When the Chair is absent, the Vice Chair shall act in his or her absence. If the Vice Chair is also absent, the most senior member of the Board shall act as the chair.
[Source: Added at 14 Ok Reg 160, eff 10-17-96 (emergency); Added at 14 Ok Reg 2319, eff 6-16-97; Amended at 37 Ok Reg 2040, eff 9-11-20]